Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 341.23B | 341.57B | 317.24B | 312.68B | 239.18B | 161.68B |
Gross Profit | 49.21B | 53.16B | 38.77B | 19.64B | 21.09B | 15.67B |
EBITDA | 20.08B | 19.46B | 13.82B | 13.83B | 15.39B | 9.98B |
Net Income | 13.01B | 13.01B | 7.65B | 8.86B | 8.06B | 6.81B |
Balance Sheet | ||||||
Total Assets | 155.17B | 155.17B | 132.62B | 132.44B | 114.80B | 90.09B |
Cash, Cash Equivalents and Short-Term Investments | 4.34B | 4.34B | 16.61B | 8.21B | 3.88B | 580.32M |
Total Debt | 7.88B | 7.88B | 10.49B | 14.54B | 36.96B | 36.60B |
Total Liabilities | 41.46B | 41.46B | 30.57B | 33.97B | 53.09B | 49.46B |
Stockholders Equity | 113.71B | 113.71B | 102.05B | 98.47B | 61.71B | 40.62B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 527.96M | 16.46B | -4.38B | 6.84B | 2.20B |
Operating Cash Flow | 0.00 | 1.97B | 17.46B | -3.39B | 7.24B | 2.41B |
Investing Cash Flow | 0.00 | -141.00M | -9.12B | 5.26B | -15.62B | -415.65M |
Financing Cash Flow | 0.00 | -6.11B | -10.15B | 2.41B | 11.67B | -3.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ₹264.66B | 32.16 | 1.27% | 4.06% | 10.78% | ||
75 Outperform | ₹337.46B | 29.50 | ― | 26.87% | 112.88% | ||
73 Outperform | ₹944.74B | 56.47 | 1.40% | 16.58% | 9.72% | ||
68 Neutral | ₹648.57B | 53.16 | 0.55% | 15.17% | 29.60% | ||
68 Neutral | ₹1.08T | 80.75 | 0.75% | 14.09% | 13.85% | ||
68 Neutral | ₹925.69B | 51.93 | 1.50% | -0.03% | -5.22% | ||
63 Neutral | $20.95B | 14.50 | -3.82% | 3.12% | 2.72% | -11.24% |
Patanjali Foods Limited announced that a previous prohibition on the sale of a batch of its Organic Wild Honey has been revoked by the Office of Administration of Union Territory of Ladakh. The revocation follows a Referral Laboratory test report confirming that the honey batch complies with food safety regulations, ensuring its safety for consumption. This development is likely to positively impact the company’s operations and market positioning by reinstating consumer confidence in its product safety standards.